Drug Trial Radar · NCT05359055
Drug-drug Interaction Study of SPH3127
Last checked: Nov 19, 2026Latest source record: Jul 29, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Dec 13, 2021
Primary completion
Jan 21, 2022
Study completion Jan 21, 2022
Sponsor
- Lead sponsor
- Shanghai Pharmaceuticals Holding Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- May 3, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A single center, open-label, fixed sequence Phase 1, drug-drug interaction (DDI) study in male healthy subjects.
Conditions
- Drug Drug Interaction
Interventions
SPH3127 tabletDrug
100mg once daily on Day 1 and Day 8
ItraconazoleDrug
200mg once daily from Day 3 to Day10.
SPH3127 tabletDrug
200mg once daily on Day 1 and Day 12.
RifampinDrug
600mg once daily from Day 3 to Day13.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum serum concentration (Cmax) of SPH3127Time frame: Up to 14 days
- Area under the serum concentration-time curve (AUC) of the Dosing Interval (0-Last) of SPH3127Time frame: Up to 14 days
- Area under the serum concentration-time curve (AUC) of the Dosing Interval (0-infinity) of SPH3127Time frame: Up to 14 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
West China Second University Hospital, Sichuan University
Chengdu, Sichuan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.